Successful management of malignant hyperthermia without dantrolene: A case report.

IF 1.5 4区医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Journal of International Medical Research Pub Date : 2025-05-01 Epub Date: 2025-05-20 DOI:10.1177/03000605251341803

Cailing Zhang, Huanbin Wang, Zhi Chen, Yuennong Zhang

引用次数: 0

Abstract

Malignant hyperthermia during surgery represents a significant challenge for anesthesiologists due to its high mortality rate and the risk of long-term physiological damage. Despite preventive measures, malignant hyperthermia cases continue to be reported. The standard and effective response involves the prompt administration of dantrolene, a specific antidote. However, dantrolene availability can differ across countries and regions; not all healthcare facilities can guarantee its immediate availability for early intervention. This case report details the successful management of malignant hyperthermia in an adult during surgery without the use of dantrolene.

查看原文本刊更多论文

不使用丹曲林成功治疗恶性高热1例报告。

手术过程中的恶性高热由于其高死亡率和长期生理损伤的风险，对麻醉医师来说是一个重大挑战。尽管采取了预防措施，恶性高热病例仍不断被报道。标准和有效的反应包括迅速给予丹曲林，一种特殊的解毒剂。然而，不同国家和地区的丹trolene供应情况不同；并非所有医疗机构都能保证立即提供早期干预。本病例报告详细介绍了成功管理恶性高热在成人手术期间不使用丹曲林。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of International Medical Research 医学-药学

CiteScore

3.20

自引率

0.00%

发文量

555

审稿时长

1 months

期刊介绍： _Journal of International Medical Research_ is a leading international journal for rapid publication of original medical, pre-clinical and clinical research, reviews, preliminary and pilot studies on a page charge basis. As a service to authors, every article accepted by peer review will be given a full technical edit to make papers as accessible and readable to the international medical community as rapidly as possible. Once the technical edit queries have been answered to the satisfaction of the journal, the paper will be published and made available freely to everyone under a creative commons licence. Symposium proceedings, summaries of presentations or collections of medical, pre-clinical or clinical data on a specific topic are welcome for publication as supplements. Print ISSN: 0300-0605